CIK 0001439222
- Large accelerated filer
AGIOS PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- AGIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 617-649-8600
- Business address
- 88 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- AGIOS PHARMACEUTICALS INC
- 4 Planned sale Chief Medical Officer sold 2,932 shares at $27.09 ($79,428)
- 4 Planned sale Chief Commercial Officer sold 2,932 shares at $27.09 ($79,428)
- 4 Planned sale Chief Financial Officer sold 2,932 shares at $27.09 ($79,428)
- 4 Planned sale Director sold 200 shares at $43.84 ($8,768)
- 4 Planned sale Chief Medical Officer sold 2,454 shares at $43.78 ($107,436)
- 4 Planned sale Chief Medical Officer sold 200 shares at $43.81 ($8,762)
- 4 Planned sale Chief Medical Officer sold 3,302 shares at $43.92 ($145,024)
- 4 Planned sale Director sold 200 shares at $41.00 ($8,200)
- 4 Planned sale Director sold 200 shares at $40.00 ($8,000)
- 4 Planned sale Chief Financial Officer sold 3,651 shares at $36.77 ($134,247)
- 4 Open-market sale Principal Accounting Officer sold 8,546 shares at $36.87 ($315,091)
- 4 Planned sale Director sold 200 shares at $40.00 ($8,000)
- 4 Option exercise Director acquired 2,302 shares (option exercise)
- 4 Option exercise Director acquired 2,302 shares (option exercise)
- 4 Planned sale Chief Executive Officer sold 11,085 shares at $36.67 ($406,487)
- 4 Planned sale Director sold 1,400 shares at $40.00 ($56,000)
- 4 Planned sale Chief Medical Officer sold 11,914 shares at an average $37.99 ($452,601)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Planned sale Chief Medical Officer sold 4,091 shares at $34.17 ($139,789)
Page 3 of 38 · 758 filings